Aesthetic Applications of Botulinum Toxin A in Asians: An International, Multidisciplinary, Pan-Asian Consensus

Abstract

Background:Botulinum toxin type A remains the most popular nonsurgical aesthetic treatment worldwide. Previous consensus statements have focused on Caucasians and on Koreans as generally representative of Asians. However, indications and dosages vary among different ethnic groups. This publication reports the results of a multidisciplinary, pan-Asian consensus focusing on incobotulinumtoxinA.Methods:A consensus group of plastic surgeons and dermatologists from Asia, Europe, and the United States convened for a live meeting in Asia, followed by a questionnaire-based Delphi procedure. Treatment of Asians in both their native countries and countries of migration was discussed.Results:For most items, the group achieved a majority consensus. A number of treatment indications, strategies, and dosages were identified in Asians, which are distinct to those previously described for Caucasians due to differences in facial morphotypes, anatomy, and cultural expectations. The group also formulated position statements for intradermal botulinum toxin type A (“mesotoxin”), body shaping with the calves as a paradigm, and reduction of parotid glands. While Asians have previously been considered a homogeneous group for the purposes of aesthetic treatment, this publication considers regional variations. A new classification of Asian facial morphotypes is proposed to aid treatment planning and implementation.Conclusions:This is the first pan-Asian consensus for aesthetic use of botulinum toxin type A. Its unique objective is to optimize treatment safety and efficacy for patients of complete or part-Asian ancestry in all regions. The recommendations for incobotulinumtoxinA may be extended with care to other botulinum toxin formulations.

The Ideals of Facial Beauty Among Chinese Aesthetic Practitioners: Results from a Large National Survey

“…Treatment strategies for aesthetic medicine need to be considerate of facial morphology, cultural and geographic ideals of beauty, and what individual patients deem attractive. For optimal treatment planning and treatment outcomes, clinicians must understand, acknowledge, and address not only the commonalities, but also the variations in ideals of beauty among their patients [ 9 ]. In addition, between each individual patient and between various ethnicities there are unique facial features and bone structures that significantly influence the outcome of any cosmetic procedure.…”

A Retrospective Study of Chinese-Specific Glabellar Contraction Patterns

“…To provide recommendations for optimal treatment strategies and develop a pan-Asian consensus on aesthetic application of BoNTA, a panel of multinational experts recently proposed a new classification of 3 Asian facial morphotypes, which are “Northern,” “Intermediate,” and “Southern” morphotypes. 22 Associated facial morphotypes are crucial factors to consider for a fully patient-tailored treatment, 21,23 and analyses of facial morphotypes may reveal further relationship between distinct facial morphotypes and specific patterns of muscular contraction. Unfortunately, the authors were not able to delve deeper into this subject in this study but hope to evaluate this relationship in the future.…”

Botulinum Toxin Type A for the Treatment of Masseter Muscle Prominence in Asian Populations

“… 4 , 6 , 8 , 25–28 In general, Asian individuals tend to have more developed and pronounced masseter muscles and a more protrusive angle of the mandible compared with most white individuals. 4 , 29 , 30 …”